Could treatment with R-HCVAD/R-MA as compared to R-CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?

Br J Haematol. 2014 Apr;165(1):145-6. doi: 10.1111/bjh.12702. Epub 2013 Dec 19.
No abstract available

Keywords: CHOP; CVAD; MYC; chemotherapy; lymphoma.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male